Document is current
Any future updates will be listed below
-
Authors
Shao, Miner
Yao, Jie
Wang, Yunke
Zhao, Lufeng
Li, Baizhou
Li, Lili
Wu, Zuqun
Chen, Zexin
Fan, Junqiang
Qiu, Fuming https://orcid.org/0000-0001-5793-1023
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81472640)
National Natural Science Foundation of China (81672802)
National Natural Science Foundation of China (82273268)
Natural Science Foundation of Zhejiang Province (No. LZ17H160004)
the Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents
The Key R&D Program of Zhejiang
- License Information
-
More Information
Article History
Received: 19 October 2022
Revised: 27 January 2023
Accepted: 8 February 2023
First Online: 10 April 2023
Competing interests
: The authors declare no competing interests.
: The neoSCORE trial was approved by the local independent ethics committee and conducted according to Good Clinical Practice and the Declaration of Helsinki. This trial was registered under ID: NCT04459611 (). All patients provided written informed consent before enrollment.
